This study will investigate the cellular, molecular, and physiological mechanisms responsible for tolerance to ?9-THC. We have produced mutant mice (S426A/S430A) expressing a desensitization- resistant form of the cannabinoid receptor 1 (CB) that exhibit delayed tolerance for ?9-THC. 1 However S426A/S430A mutants eventually become completely tolerant to ?9-THC. Treatment of S426A/S430A mutant with an inhibitor of c-Jun N-terminal kinase (JNK) eliminates tolerance to the analgesic effects of ?9-THC suggesting that this signaling pathway might be responsible for the residual tolerance observed in S426A/S430A mutant mice. The specific JNK isoform involved in cannabinoid tolerance will be determined by measuring tolerance for the analgesic, hypothermic, and cataleptic effects of ?9-THC in wild-type, S426A/S430A x JNK1 knockout (KO), and S426A/S430A x JNK2 KO double mutant mice. A dose response curve for the preventative effects of SP600125 (JNK inhibitor) on hypothermic, cataleptic, and analgesic tolerance will be examined in S426A/S430A single mutant mice to determine an optimal dosage for this inhibitor. Microarray analyses examining differences in gene expression between vehicle and SP600125-treated S426A/S430A mutants as well between S426A/S430A single mutants and S426A/S430A x JNK1 and S426A/S430A x JNK2 KO double mutants will be done to determine the molecular targets responsible for JNK-mediated cannabinoid tolerance. All putative JNK targets identified by microarray analysis will be validated using quantitative real-time PCR. The goal of this study is to determine the form of JNK responsible for mediating tolerance to the analgesic effects of ?9-THC and also to identify the molecular and biochemical targets of JNK that are responsible for cannabinoid tolerance.
We have found that pharmacological inhibition of c-Jun N-terminal kinase (JNK) in mutant mice that are unable undergo G-protein coupled receptor kinase-mediated cannabinoid receptor 1 desensitization prevents tolerance to the analgesic effects of ?9-THC. This study will determine the form of JNK that is responsible for mediating tolerance to ?9-THC. This study will also identify and validate molecular targets involved in JNK-mediated cannabinoid tolerance.
|Yuill, Matthew B; Zee, Michael L; Marcus, David et al. (2016) Tolerance to the antinociceptive and hypothermic effects of morphine is mediated by multiple isoforms of c-Jun N-terminal kinase. Neuroreport 27:392-6|
|Henderson-Redmond, Angela N; Guindon, JosÃ©e; Morgan, Daniel J (2016) Roles for the endocannabinoid system in ethanol-motivated behavior. Prog Neuropsychopharmacol Biol Psychiatry 65:330-9|
|Henderson-Redmond, Angela N; Yuill, Matthew B; Lowe, Tammy E et al. (2016) Morphine-induced antinociception and reward in ""humanized"" mice expressing the mu opioid receptor A118G polymorphism. Brain Res Bull 123:5-12|
|Marcus, David J; Zee, Michael; Hughes, Alex et al. (2015) Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinase. Mol Pain 11:34|
|Morgan, Daniel J; Davis, Brian J; Kearn, Chris S et al. (2014) Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice. J Neurosci 34:5152-63|